Want to Ensure Your AOM Spend is Worth the Investment? Create an Effective and Affordable Obesity Program

Given the current 42% US obesity rate and powerful results from the new anti-obesity medications (AOMs), employers and others responsible for healthcare benefits decisions are feeling pressure to add coverage for these expensive AOMs to employee health benefits plans. However, with a recent study showing 65% weight regain after patients stop taking their AOM meds, …



Traditional US Obesity Programs Have Failed Us – But New Science Provides Hope and a Path Forward

There is an intense media focus on the arrival of a new class of Anti Obesity Medications (AOMs) and a robust national discussion to clarify their value (“bang for the buck”) given the mix of positives (significant clinical benefits) and negatives (side effects, weight regain on stopping, and high price tag). This is the first …